Research Reports | Market Assessment
March 2019

Chronic Pain | Unmet Need | Fibromyalgia | US/EU5 | 2019

Fibromyalgia is a chronic condition characterized by pain and tenderness. The primary goal of treatment is to reduce the pain, for which multiple well-established treatment options are available, many of which are generic. Even though the majority of the diagnosed fibromyalgia population receives prescription drug treatment, most current therapies suffer from shortcomings in efficacy. The substantial percentage of patients with inadequate pain relief, together with the need for improvement in the treatment of secondary symptoms (e.g., anxiety, major depressive disorder, fatigue) and other areas bearing large unmet need (e.g., drugs that restore neuronal function), poses ample commercial opportunity for a new drug to improve fibromyalgia treatment.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports